size is expected to reach USD 1,154.2 million by 2027 and is registering a commendable CAGR of 9.2% From 2020-2027 The rise in the cases of chronic diseases such as diabetes and cancer is a key factor fueling market growth. Unhealthy lifestyle habits of smoking and alcohol consumption have resulted in the increased prevalence of non-communicable diseases which in turn drives the global market. In addition to this, physicians higher recommendation for anti-biofilm wound dressing products to treat chronic diseases further drives the market growth. A rise in the incidence of injuries during participation in sports and recreational activities propels the growth of the market. Apart from that, huge investment in healthcare infrastructure, technological advancements, and favorable government policies are also augmenting the growth of the global market for anti-biofilm wound dressing.
Share this article
Share this article
USD 23.67 billion by 2027 according to a new study conducted by
Polaris Market Research. The market is
anticipated to register a CAGR of 2.9%
From
2020 – 2027.
An increase in COVID-19 patients across the world and the need for rapid diagnostics are anticipated to drive the growth of the global market. Several countries are conducting testing for the diagnosis of COVID-19 and to isolate patients affected by the virus, helping to limit its spread is one of the key factors boosting the market growth. Rising awareness among physicians and patients regarding the crucial benefits of COVID-19 diagnostics is positively influencing the market. Increased fear among people for infectious virus coupled with healthcare professional s suggestions for early diagnostics to contain the risk of virus infection, boost the global COVID-19 diagnostics market. The rise in government initiatives and programs to encourage early diagnostic testing